Global Minimally Invasive Surgery Market Overview

The Global Minimally Invasive Surgery Market size is expected to grow from USD 63.18 Billion in 2023 to USD 139.39 Billion by 2032, at a CAGR of 9.19% during the forecast period (2024-2032).

Minimally Invasive Surgery (MIS) represents a transformative approach in modern surgical practices, characterized by procedures that minimize incisions and reduce recovery times compared to traditional open surgeries. These techniques involve the use of specialized instruments, including endoscopes, laparoscopes, and robotic systems, to perform surgeries with minimal damage to surrounding tissues. The global MIS market, valued at approximately USD 35 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 8% through 2030, driven by advancements in surgical technology, increasing patient preference for less invasive procedures, and the growing burden of chronic diseases.

Technological advancements are at the forefront of the MIS market's expansion. The development of robotic-assisted surgery, exemplified by systems like the da Vinci Surgical System, allows for enhanced precision, flexibility, and control during complex procedures. Innovations in imaging and visualization, such as 3D imaging and augmented reality (AR), are enhancing surgeons’ capabilities to perform intricate surgeries with greater accuracy. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in surgical planning and intraoperative guidance is transforming surgical practices, leading to improved outcomes and efficiency.

Market Dynamics and Key Factors of Minimally Invasive Surgery Market

Drivers:

The rise in the number of individuals suffering from cancer and cardiovascular diseases is the main factor promoting the expansion of the minimally invasive surgery market during the forecast period. Scars from minimally invasive surgery are smaller than the traditional open surgery. In laparoscopy, one incision is done in the belly button and one to three others in the lower belly. The hospital stay period is gradually reduced and it decreases the risk for problems such as blood clots or infection post-surgery thus, supporting the development of minimally invasive surgery market over the projected period.

Less and smaller incisions are made in minimally invasive surgery methods thereby, it is a less painful procedure than traditional open surgery methods. As the patient suffers less pain, the requirement for pain killers eventually decreases. Moreover, minimally invasive surgery increases the recovery time, and there is a high reduction in blood loss during surgery as small cuts are made. The growing awareness among individuals about the benefits of minimally invasive surgery methods is the essential factor stimulating the growth of the minimally invasive surgery market. According to a report published by NCBI, 310 million major surgeries are performed each year. This large number can be attributed to the rising adult population and the change in lifestyle that has fueled the rise in cardiovascular and other chronic disorders across every age group. Furthermore, the growing senior citizen population and their higher susceptibility to diseases that requires surgical procedures are promoting the expansion of the minimally invasive surgery market in the projected period.

Restraints:

The main factor hampering the expansion of the minimally invasive surgery market is the high cost associated with the surgical procedures. Moreover, stringent government rules and regulations while approving a novel technique to be administered in minimally invasive surgeries is another factor declining the growth of the market. Furthermore, robotic surgery a subtype of minimally invasive surgery method takes a longer time to set up the robotic equipment and sometimes may take a longer time than open surgery. There are possible risks associated with general anesthesia and infections as it pertains to any surgery thus, hindering the development of the minimally invasive surgery market during the projected period.

Opportunities:

The investments made by several governments and private organizations to develop novel surgery methods that can reduce the risk associated with the traditional open surgery methods is creating a lucrative opportunity for the market players. The trend is set to see an upsurge in demand as individuals are becoming aware of the advantages of minimally invasive surgery methods such as quick recovery time, and less blood loss. Moreover, the rise in the population opting for minimally invasive surgical procedures and the adoption of these techniques by several healthcare providers is generating profitable opportunities for the market players involved in the minimally invasive surgery market.

Market Segmentation

Segmentation Analysis of Minimally Invasive Surgery Market:

Depending on device, the surgical device segment is anticipated to dominate the minimally invasive surgery market during the projected period. More than 59 million surgical procedures are performed every year in the US, and out of which, 85 percent utilize electrosurgical devices. These devices are frequently utilized during surgical operations such as eye surgery to cut, coagulate, dissect, fulgurate, ablate and shrink tissue. Surgical devices play an important part in minimally invasive surgery procedures thus, driving the growth of the segment. Surgical device segment is expected to reach US$ 47 billion by the end of the analysis period.

Depending on the surgery method, the traditional segment is expected to lead the minimally invasive surgery market in the projected period. The cost involved in the traditional method of laparoscopic surgery is low as compared to robotic laparoscopic. Moreover, the traditional method requires less training period and can be easily administered by medical professionals thus, supporting the development of this segment. The robot-assisted segment is predicted to have a significant growth rate in the forecast period. The technological advancement and the growing research and development activities in robotics are the main factors stimulating the development of this segment. The da Vinci surgical system developed by Intuitive Surgical is the most advance robotic system utilized for minimally invasive surgery procedures. Many hospitals around the globe have added da Vinci surgical system to upgrade their medical services thus, promoting the growth of this segment.

Depending on surgery type, the orthopedic segment is forecasted to have the highest share of the minimally invasive surgery market. With the rise in the aging population, there is an increase in orthopedic patients, with 6.6 million orthopedic surgeries occurring annually by 2020. Moreover, orthopedic issues are the most common reason for which individuals seek medical care, with one in seven Americans reporting an orthopedic-related disorder the demand for minimally invasive orthopedic surgeries is going to increase in the forecast period.

Depending on end-users, the hospital segment is forecasted to be the prominent shareholder of the minimally invasive surgery market. With the majority of individuals preferring hospitals for surgical procedures due to highly skilled healthcare professionals, the demand for minimally invasive surgery methods has seen a rise. In addition, other essential medical facilities are provided under one roof. Furthermore, patients are more satisfied while getting treated in hospitals thus, promoting the expansion of this segment.

Regional Analysis of Minimally Invasive Surgery Market:

North America leads the global market for Minimally Invasive Surgery (MIS), driven by its advanced healthcare infrastructure, high patient awareness, and significant investments in surgical technology. The United States is at the forefront, with extensive adoption of MIS procedures in various medical fields, including cardiology, orthopedics, and gynecology. The presence of key industry players such as Intuitive Surgical, Stryker, and Medtronic contributes to the rapid integration of cutting-edge technologies like robotic-assisted surgery and advanced imaging systems. The region also benefits from a favorable regulatory environment and substantial funding for research and development, enabling continuous innovation in MIS techniques and devices. Canada also plays a crucial role, particularly in developing and implementing laparoscopic and endoscopic procedures, supported by a well-structured healthcare system and increasing investments in medical technology.

The global Minimally Invasive Surgery (MIS) industry exhibits varied levels of adoption and growth across different regions. North America and Europe lead in terms of technological advancements and market penetration, driven by robust healthcare infrastructure and a focus on innovation. Asia-Pacific shows the fastest growth, propelled by demographic trends and rapid healthcare development. Latin America and the Middle East & Africa present emerging markets with growing potential, although they face challenges related to infrastructure and economic disparities.

Players Covered in Minimally Invasive Surgery Market are:

• NuVasive Inc (US)
• Siemens Healthineers (Germany)
• Stryker Corporation (US)
• Teleflex Inc. (US)
• Intuitive Surgical (US)
• Beverly Hills Orthopedic Institute (US)
• Boston Center for Ambulatory Surgery Inc. (US)
• Weill Cornell Medicine (US)
• Smart Medical Devices Inc. (US)
• Taiwan Surgical Corporation (Taiwan)
• Tissium (France)
• ZSX Medical LLC (US)
• Ancillary Advantage Inc. (US) and other major players.

Recent Industry Developments in Minimally Invasive Surgery Market:

• In March 2024, Medtronic plc a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.
• In March 2024, Siemens Healthineers developed the Ciartic Move3 automated C-arm system for intraoperative imaging in surgery. The system features holonomic, omnidirectional wheels for precise movements and easy positioning. It can be moved to previously stored positions with a touch of a button using a remote control, reducing the burden on technologists. The automated process saves time by making automatic adjustments more precise, reducing imaging times by around 50% in spine, pelvic, and distal radius surgery
• In June 2024, Intuitive Surgical (NASDAQ: ISRG) secured FDA clearance for its fifth generation da Vinci 5 robotic system, enhancing minimally invasive surgery with over 150 technological advancements. Key features include improved precision, 3D imaging, and novel Force Feedback technology, promising better surgical outcomes and workflow efficiency. This innovation signifies a leap forward for robotic-assisted surgery, aiming to reduce surgical trauma and optimize operating room performance.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Device
 3.2 By Surgery Method
 3.3 By Type of Surgery
 3.4 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Minimally Invasive Surgery Market by Device
 5.1 Minimally Invasive Surgery Market Overview Snapshot and Growth Engine
 5.2 Minimally Invasive Surgery Market Overview
 5.3 Surgical Devices
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Surgical Devices: Grographic Segmentation
 5.4 Monitoring & Visualization Devices
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Monitoring & Visualization Devices: Grographic Segmentation
 5.5 Endoscopy Devices
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Endoscopy Devices: Grographic Segmentation

Chapter 6: Minimally Invasive Surgery Market by Surgery Method
 6.1 Minimally Invasive Surgery Market Overview Snapshot and Growth Engine
 6.2 Minimally Invasive Surgery Market Overview
 6.3 Robot-Assisted
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Robot-Assisted: Grographic Segmentation
 6.4 Traditional
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Traditional: Grographic Segmentation

Chapter 7: Minimally Invasive Surgery Market by Type of Surgery
 7.1 Minimally Invasive Surgery Market Overview Snapshot and Growth Engine
 7.2 Minimally Invasive Surgery Market Overview
 7.3 Gastrointestinal
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Gastrointestinal: Grographic Segmentation
 7.4 Cardiothoracic
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Cardiothoracic: Grographic Segmentation
 7.5 Gynecological
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Gynecological: Grographic Segmentation
 7.6 Urological
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Urological: Grographic Segmentation
 7.7 Orthopedic
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2017-2032F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Orthopedic: Grographic Segmentation
 7.8 Others
  7.8.1 Introduction and Market Overview
  7.8.2 Historic and Forecasted Market Size (2017-2032F)
  7.8.3 Key Market Trends, Growth Factors and Opportunities
  7.8.4 Others: Grographic Segmentation

Chapter 8: Minimally Invasive Surgery Market by End-User
 8.1 Minimally Invasive Surgery Market Overview Snapshot and Growth Engine
 8.2 Minimally Invasive Surgery Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2017-2032F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Grographic Segmentation
 8.4 Ambulatory Surgery Centers
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2017-2032F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Ambulatory Surgery Centers: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Minimally Invasive Surgery Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Minimally Invasive Surgery Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Minimally Invasive Surgery Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 NUVASIVE INC
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 SIEMENS HEALTHINEERS
 9.4 STRYKER CORPORATION
 9.5 TELEFLEX INC.
 9.6 INTUITIVE SURGICAL
 9.7 BEVERLY HILLS ORTHOPEDIC INSTITUTE
 9.8 BOSTON CENTER FOR AMBULATORY SURGERY INC
 9.9 WEILL CORNELL MEDICINE
 9.10 SMART MEDICAL DEVICES INC.
 9.11 TAIWAN SURGICAL CORPORATION
 9.12 TISSIUM
 9.13 ZSX MEDICAL LLC
 9.14 ANCILLARY ADVANTAGE INC.
 9.15 OTHER MAJOR PLAYERS

Chapter 10: Global Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Device
  10.2.1 Surgical Devices
  10.2.2 Monitoring & Visualization Devices
  10.2.3 Endoscopy Devices
 10.3 Historic and Forecasted Market Size By Surgery Method
  10.3.1 Robot-Assisted
  10.3.2 Traditional
 10.4 Historic and Forecasted Market Size By Type of Surgery
  10.4.1 Gastrointestinal
  10.4.2 Cardiothoracic
  10.4.3 Gynecological
  10.4.4 Urological
  10.4.5 Orthopedic
  10.4.6 Others
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Hospitals
  10.5.2 Ambulatory Surgery Centers

Chapter 11: North America Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Device
  11.4.1 Surgical Devices
  11.4.2 Monitoring & Visualization Devices
  11.4.3 Endoscopy Devices
 11.5 Historic and Forecasted Market Size By Surgery Method
  11.5.1 Robot-Assisted
  11.5.2 Traditional
 11.6 Historic and Forecasted Market Size By Type of Surgery
  11.6.1 Gastrointestinal
  11.6.2 Cardiothoracic
  11.6.3 Gynecological
  11.6.4 Urological
  11.6.5 Orthopedic
  11.6.6 Others
 11.7 Historic and Forecasted Market Size By End-User
  11.7.1 Hospitals
  11.7.2 Ambulatory Surgery Centers
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Device
  12.4.1 Surgical Devices
  12.4.2 Monitoring & Visualization Devices
  12.4.3 Endoscopy Devices
 12.5 Historic and Forecasted Market Size By Surgery Method
  12.5.1 Robot-Assisted
  12.5.2 Traditional
 12.6 Historic and Forecasted Market Size By Type of Surgery
  12.6.1 Gastrointestinal
  12.6.2 Cardiothoracic
  12.6.3 Gynecological
  12.6.4 Urological
  12.6.5 Orthopedic
  12.6.6 Others
 12.7 Historic and Forecasted Market Size By End-User
  12.7.1 Hospitals
  12.7.2 Ambulatory Surgery Centers
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Device
  13.4.1 Surgical Devices
  13.4.2 Monitoring & Visualization Devices
  13.4.3 Endoscopy Devices
 13.5 Historic and Forecasted Market Size By Surgery Method
  13.5.1 Robot-Assisted
  13.5.2 Traditional
 13.6 Historic and Forecasted Market Size By Type of Surgery
  13.6.1 Gastrointestinal
  13.6.2 Cardiothoracic
  13.6.3 Gynecological
  13.6.4 Urological
  13.6.5 Orthopedic
  13.6.6 Others
 13.7 Historic and Forecasted Market Size By End-User
  13.7.1 Hospitals
  13.7.2 Ambulatory Surgery Centers
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Device
  14.4.1 Surgical Devices
  14.4.2 Monitoring & Visualization Devices
  14.4.3 Endoscopy Devices
 14.5 Historic and Forecasted Market Size By Surgery Method
  14.5.1 Robot-Assisted
  14.5.2 Traditional
 14.6 Historic and Forecasted Market Size By Type of Surgery
  14.6.1 Gastrointestinal
  14.6.2 Cardiothoracic
  14.6.3 Gynecological
  14.6.4 Urological
  14.6.5 Orthopedic
  14.6.6 Others
 14.7 Historic and Forecasted Market Size By End-User
  14.7.1 Hospitals
  14.7.2 Ambulatory Surgery Centers
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Minimally Invasive Surgery Market Analysis, Insights and Forecast, 2017-2032
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Device
  15.4.1 Surgical Devices
  15.4.2 Monitoring & Visualization Devices
  15.4.3 Endoscopy Devices
 15.5 Historic and Forecasted Market Size By Surgery Method
  15.5.1 Robot-Assisted
  15.5.2 Traditional
 15.6 Historic and Forecasted Market Size By Type of Surgery
  15.6.1 Gastrointestinal
  15.6.2 Cardiothoracic
  15.6.3 Gynecological
  15.6.4 Urological
  15.6.5 Orthopedic
  15.6.6 Others
 15.7 Historic and Forecasted Market Size By End-User
  15.7.1 Hospitals
  15.7.2 Ambulatory Surgery Centers
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MINIMALLY INVASIVE SURGERY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MINIMALLY INVASIVE SURGERY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MINIMALLY INVASIVE SURGERY MARKET COMPETITIVE RIVALRY
TABLE 005. MINIMALLY INVASIVE SURGERY MARKET THREAT OF NEW ENTRANTS
TABLE 006. MINIMALLY INVASIVE SURGERY MARKET THREAT OF SUBSTITUTES
TABLE 007. MINIMALLY INVASIVE SURGERY MARKET BY DEVICE
TABLE 008. SURGICAL DEVICES MARKET OVERVIEW (2016-2028)
TABLE 009. MONITORING & VISUALIZATION DEVICES MARKET OVERVIEW (2016-2028)
TABLE 010. ENDOSCOPY DEVICES MARKET OVERVIEW (2016-2028)
TABLE 011. MINIMALLY INVASIVE SURGERY MARKET BY SURGERY METHOD
TABLE 012. ROBOT-ASSISTED MARKET OVERVIEW (2016-2028)
TABLE 013. TRADITIONAL MARKET OVERVIEW (2016-2028)
TABLE 014. MINIMALLY INVASIVE SURGERY MARKET BY TYPE OF SURGERY
TABLE 015. GASTROINTESTINAL MARKET OVERVIEW (2016-2028)
TABLE 016. CARDIOTHORACIC MARKET OVERVIEW (2016-2028)
TABLE 017. GYNECOLOGICAL MARKET OVERVIEW (2016-2028)
TABLE 018. UROLOGICAL MARKET OVERVIEW (2016-2028)
TABLE 019. ORTHOPEDIC MARKET OVERVIEW (2016-2028)
TABLE 020. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 021. MINIMALLY INVASIVE SURGERY MARKET BY END-USER
TABLE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 023. AMBULATORY SURGERY CENTERS MARKET OVERVIEW (2016-2028)
TABLE 024. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY DEVICE (2016-2028)
TABLE 025. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY SURGERY METHOD (2016-2028)
TABLE 026. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY TYPE OF SURGERY (2016-2028)
TABLE 027. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY END-USER (2016-2028)
TABLE 028. N MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY (2016-2028)
TABLE 029. EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY DEVICE (2016-2028)
TABLE 030. EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY SURGERY METHOD (2016-2028)
TABLE 031. EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY TYPE OF SURGERY (2016-2028)
TABLE 032. EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY END-USER (2016-2028)
TABLE 033. MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY (2016-2028)
TABLE 034. ASIA PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY DEVICE (2016-2028)
TABLE 035. ASIA PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY SURGERY METHOD (2016-2028)
TABLE 036. ASIA PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY TYPE OF SURGERY (2016-2028)
TABLE 037. ASIA PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY END-USER (2016-2028)
TABLE 038. MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY DEVICE (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY SURGERY METHOD (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY TYPE OF SURGERY (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY END-USER (2016-2028)
TABLE 043. MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY (2016-2028)
TABLE 044. SOUTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY DEVICE (2016-2028)
TABLE 045. SOUTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY SURGERY METHOD (2016-2028)
TABLE 046. SOUTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY TYPE OF SURGERY (2016-2028)
TABLE 047. SOUTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY END-USER (2016-2028)
TABLE 048. MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY (2016-2028)
TABLE 049. NUVASIVE INC: SNAPSHOT
TABLE 050. NUVASIVE INC: BUSINESS PERFORMANCE
TABLE 051. NUVASIVE INC: PRODUCT PORTFOLIO
TABLE 052. NUVASIVE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. SIEMENS HEALTHINEERS: SNAPSHOT
TABLE 053. SIEMENS HEALTHINEERS: BUSINESS PERFORMANCE
TABLE 054. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 055. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. STRYKER CORPORATION: SNAPSHOT
TABLE 056. STRYKER CORPORATION: BUSINESS PERFORMANCE
TABLE 057. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 058. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. TELEFLEX INC.: SNAPSHOT
TABLE 059. TELEFLEX INC.: BUSINESS PERFORMANCE
TABLE 060. TELEFLEX INC.: PRODUCT PORTFOLIO
TABLE 061. TELEFLEX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. INTUITIVE SURGICAL: SNAPSHOT
TABLE 062. INTUITIVE SURGICAL: BUSINESS PERFORMANCE
TABLE 063. INTUITIVE SURGICAL: PRODUCT PORTFOLIO
TABLE 064. INTUITIVE SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. BEVERLY HILLS ORTHOPEDIC INSTITUTE: SNAPSHOT
TABLE 065. BEVERLY HILLS ORTHOPEDIC INSTITUTE: BUSINESS PERFORMANCE
TABLE 066. BEVERLY HILLS ORTHOPEDIC INSTITUTE: PRODUCT PORTFOLIO
TABLE 067. BEVERLY HILLS ORTHOPEDIC INSTITUTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. BOSTON CENTER FOR AMBULATORY SURGERY INC: SNAPSHOT
TABLE 068. BOSTON CENTER FOR AMBULATORY SURGERY INC: BUSINESS PERFORMANCE
TABLE 069. BOSTON CENTER FOR AMBULATORY SURGERY INC: PRODUCT PORTFOLIO
TABLE 070. BOSTON CENTER FOR AMBULATORY SURGERY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. WEILL CORNELL MEDICINE: SNAPSHOT
TABLE 071. WEILL CORNELL MEDICINE: BUSINESS PERFORMANCE
TABLE 072. WEILL CORNELL MEDICINE: PRODUCT PORTFOLIO
TABLE 073. WEILL CORNELL MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. SMART MEDICAL DEVICES INC.: SNAPSHOT
TABLE 074. SMART MEDICAL DEVICES INC.: BUSINESS PERFORMANCE
TABLE 075. SMART MEDICAL DEVICES INC.: PRODUCT PORTFOLIO
TABLE 076. SMART MEDICAL DEVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. TAIWAN SURGICAL CORPORATION: SNAPSHOT
TABLE 077. TAIWAN SURGICAL CORPORATION: BUSINESS PERFORMANCE
TABLE 078. TAIWAN SURGICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 079. TAIWAN SURGICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. TISSIUM: SNAPSHOT
TABLE 080. TISSIUM: BUSINESS PERFORMANCE
TABLE 081. TISSIUM: PRODUCT PORTFOLIO
TABLE 082. TISSIUM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. ZSX MEDICAL LLC: SNAPSHOT
TABLE 083. ZSX MEDICAL LLC: BUSINESS PERFORMANCE
TABLE 084. ZSX MEDICAL LLC: PRODUCT PORTFOLIO
TABLE 085. ZSX MEDICAL LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. ANCILLARY ADVANTAGE INC.: SNAPSHOT
TABLE 086. ANCILLARY ADVANTAGE INC.: BUSINESS PERFORMANCE
TABLE 087. ANCILLARY ADVANTAGE INC.: PRODUCT PORTFOLIO
TABLE 088. ANCILLARY ADVANTAGE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 089. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 090. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 091. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY DEVICE
FIGURE 012. SURGICAL DEVICES MARKET OVERVIEW (2016-2028)
FIGURE 013. MONITORING & VISUALIZATION DEVICES MARKET OVERVIEW (2016-2028)
FIGURE 014. ENDOSCOPY DEVICES MARKET OVERVIEW (2016-2028)
FIGURE 015. MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY SURGERY METHOD
FIGURE 016. ROBOT-ASSISTED MARKET OVERVIEW (2016-2028)
FIGURE 017. TRADITIONAL MARKET OVERVIEW (2016-2028)
FIGURE 018. MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY TYPE OF SURGERY
FIGURE 019. GASTROINTESTINAL MARKET OVERVIEW (2016-2028)
FIGURE 020. CARDIOTHORACIC MARKET OVERVIEW (2016-2028)
FIGURE 021. GYNECOLOGICAL MARKET OVERVIEW (2016-2028)
FIGURE 022. UROLOGICAL MARKET OVERVIEW (2016-2028)
FIGURE 023. ORTHOPEDIC MARKET OVERVIEW (2016-2028)
FIGURE 024. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 025. MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY END-USER
FIGURE 026. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 027. AMBULATORY SURGERY CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 028. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. EUROPE MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. ASIA PACIFIC MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. SOUTH AMERICA MINIMALLY INVASIVE SURGERY MARKET OVERVIEW BY COUNTRY (2016-2028)